[ET Net News Agency, 4 March 2024] CSTONE PHARMA-B (02616) fell 30.4% to HK$1.03.
It hits an intra-day low of HK$1.02, hitting a historical low, and an intra-day high of
HK$1.47. The total shares traded was 5.52 million, with a value of HK$6.75m. The active
buy/sell ratio is 30:70, with net selling turnover of HK$2.61m. FUTU SEC INT'L accounts
for greatest net responsive buying turnover of HK$530,402, with volume weighted average
price of HK$1.247. CHINA INV INFO accounts for greatest net responsive selling turnover of
HK$549,096, with volume weighted average price of HK$1.287. The stock has fallen a
combined 35.6% over the past 2 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 1.030 % Chg -30.41%
High 1.470 Low 1.020
Shares Tr 5.52m Turnover 6.75m
10-D SMA 1.522 %H.V 69.322
20-D SMA 1.542 VWAP 1.224
50-D SMA 1.848 RSI14 21.575
---------------------------------
Status: Hitting a historical low, active buy/sell ratio is 30:70, with net selling
turnover of HK$2.61m, falling a combined 35.6% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 1.03 -30.41
GENSCRIPT BIO (01548) 16.32 +5.29
INNOVENT BIO (01801) 40.95 +3.15
EVEREST MED-B (01952) 25.15 +3.71
LAEKNA-B (02105) 8.28 +14.05
WUXI XDC (02268) 22.30 +19.51
WUXI BIO (02269) 20.90 +11.17
BEIGENE (06160) 101.00 +4.07
SKB BIO-B (06990) 116.60 +12.44
AKESO (09926) 48.20 +3.21
-----------------------------------------------
(ed)